Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0.6
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Favourable price performance
Data is available to registered users only
Data is available to registered users only
About
HealthSpan Medical Systems, Inc. develops marijuana based intravenous therapy (IV) infusion blends for healthcare practitioners. The company was incorporated in 2018 and is headquartered in Ft. Lauderdale, Florida.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is overpriced on P/E, of fair value o
Data is available to registered users only
Buy
Sell